Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation: A Randomized Controlled Trial

Lignende værker

• A multicenter, longitudinal, interventional, double blind randomized clinical trial in hematopoietic cell transplant recipients residing in remote areas: Lessons learned from the late cytomegalovirus prevention trial
  af: Kimball, Louise E., et al.
  Udgivet: (2016)
• Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation
  af: Hill, Joshua A, et al.
  Udgivet: (2018)
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
  af: Marty, Francisco M., et al.
  Udgivet: (2018)
• 750. Respiratory Virus Infections and Airflow Obstruction After Allogeneic Hematopoietic Cell Transplantation
  af: Boeckh, Michael, et al.
  Udgivet: (2018)
• Donor-Derived CD4(+) T Cells and Human Herpesvirus 6B Detection After Allogeneic Hematopoietic Cell Transplantation
  af: Hanson, Derek J, et al.
  Udgivet: (2020)